Intraneural ganglion cysts (INGCs) are benign, fluid-filled sacs that develop within the epineurium of peripheral nerves, often leading to various neurological symptoms. These cysts can arise from ...

Ruptured ovarian cysts happen when these fluid-filled sacs in the ovaries break. The ovarian cyst wall opens up, which exposes the fluid in the cyst to your abdominal cavity. Physical activity or ...

Ovarian endometrioma is a benign, estrogen-dependent cyst found in women of reproductive age. Infertility is associated with ovarian endometriomas; although the exact cause is unknown, oocyte ...

A Bartholin's cyst, also known as Bartholin's gland cyst or a Bartholin’s duct cyst, occurs when one of two glands at the vaginal opening fills up with fluid. You can treat a Bartholin’s cyst at home ...

Ovarian cancer often develops silently, making early detection crucial for effective treatment. While sometimes called a “silent disease,” it does present warning signs that women should ...

SINGAPORE – Imagine a bustling city with millions of residents, each playing a unique role in the maintenance of collective harmony. Now think of your mouth as such a city, with the oral ...

Background Intraoral scanners (IOS) are devices for capturing direct optical impressions in dentistry. The purpose of this narrative review on the use of IOS was to: (1) identify the advantages ...

Causes: A cyst is a fluid-filled sac that develops inside the ovary. They are very common, especially in women in their thirties and forties, and almost always harmless. In fact, they can occur ...

The easy-to-use CS 1600 combines exclusive potential caries identification technology with industry-leading image quality. The result is one multi-purpose tool that’s designed to improve ...

Resveratrol supplementation in wet AMD patients led to fewer aflibercept injections and reduced macular fibrosis progression over two years. Both treatment groups showed significant improvements ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...